Home/Pipeline/Vanquish Water Vapor Ablation System

Vanquish Water Vapor Ablation System

Targeted ablation of prostate tissue / Management of localized intermediate-risk prostate cancer

Pivotal TrialActive

Key Facts

Indication
Targeted ablation of prostate tissue / Management of localized intermediate-risk prostate cancer
Phase
Pivotal Trial
Status
Active
Company

About Francis Medical

Francis Medical is an innovative medical device company pioneering water vapor ablation therapy for prostate cancer. Its core technology, the Vanquish System, delivers sterile water vapor to ablate targeted prostate tissue with the aim of being effective while minimizing damage to surrounding structures and reducing side effects like incontinence and erectile dysfunction. The company is currently generating clinical evidence through its VAPOR 2 multi-center pivotal study to support the system's use in managing localized, intermediate-risk prostate cancer. As a private firm, it is in the commercial stage for its device as an ablation tool but is still seeking broader therapeutic claims from the FDA.

View full company profile

Therapeutic Areas